Medical Ikkou GroupMedical Ikkou Group Co.,Ltd.3353東証スタンダード小売業FY ending Feb 2026, consolidated, J-GAAP

Medical Ikkou Group revenue and profit

Out of every ¥100 of sales, about ¥3 is left as operating profit. Revenue changed +13.6% from the prior year, operating profit +5.7%.

Five-year trend

Revenue¥55B
FY ending Feb 2022: ¥33.6B¥33.6BFY ending Feb 2023: ¥33.9B¥33.9BFY ending Feb 2024: ¥39.9B¥39.9BFY ending Feb 2025: ¥48.4B¥48.4BFY ending Feb 2026: ¥55B¥55BFY22FY23FY24FY25FY26
Operating income¥1.79B
FY ending Feb 2022: ¥1.28B¥1.28BFY ending Feb 2023: ¥935.2M¥935.2MFY ending Feb 2024: ¥1.56B¥1.56BFY ending Feb 2025: ¥1.69B¥1.69BFY ending Feb 2026: ¥1.79B¥1.79BFY22FY23FY24FY25FY26
Operating margin3.3%
FY ending Feb 2022: 3.8%3.8%FY ending Feb 2023: 2.8%2.8%FY ending Feb 2024: 3.9%3.9%FY ending Feb 2025: 3.5%3.5%FY ending Feb 2026: 3.3%3.3%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin2.3%
Asset turnover1.53×
ROA3.6%
ROA3.6%
Financial leverage2.51×
ROE8.9%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin2.3%
2022: 2.5%2.5%2023: 2.2%2.2%2024: 2.6%2.6%2025: 2.3%2.3%2026: 2.3%2.3%2223242526
Asset turnover1.53×
2022: 1.15×1.15×2023: 1.20×1.20×2024: 1.35×1.35×2025: 1.47×1.47×2026: 1.53×1.53×2223242526
ROA3.6%
2022: 2.9%2.9%2023: 2.7%2.7%2024: 3.5%3.5%2025: 3.4%3.4%2026: 3.6%3.6%2223242526
Financial leverage2.51×
2022: 2.55×2.55×2023: 2.42×2.42×2024: 2.37×2.37×2025: 2.46×2.46×2026: 2.51×2.51×2223242526
ROE8.9%
2022: 7.5%7.5%2023: 6.5%6.5%2024: 8.3%8.3%2025: 8.5%8.5%2026: 8.9%8.9%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
20222.5%1.15×2.9%2.55×7.5%
20232.2%1.20×2.7%2.42×6.5%
20242.6%1.35×3.5%2.37×8.3%
20252.3%1.47×3.4%2.46×8.5%
20262.3%1.53×3.6%2.51×8.9%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue19.8%
2021: 32.0%32.0%2022: 29.4%29.4%2023: 28.3%28.3%2024: 22.8%22.8%2025: 20.8%20.8%2026: 19.8%19.8%212223242526
PPE ÷ total assets29.0%
2021: 35.4%35.4%2022: 33.9%33.9%2023: 34.9%34.9%2024: 28.8%28.8%2025: 29.3%29.3%2026: 29.0%29.0%212223242526
Goodwill ÷ parent equity5.2%
2021: 16.7%16.7%2022: 13.5%13.5%2023: 10.8%10.8%2024: 5.4%5.4%2025: 5.9%5.9%2026: 5.2%5.2%212223242526
Goodwill balance¥774.7M
2021: ¥1.75B¥1.75B2022: ¥1.54B¥1.54B2023: ¥1.3B¥1.3B2024: ¥692.8M¥692.8M2025: ¥816.4M¥816.4M2026: ¥774.7M¥774.7M212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Income statement (JPY millions)

ItemFY ending Feb 2022FY ending Feb 2023FY ending Feb 2024FY ending Feb 2025FY ending Feb 2026
Revenue33,59633,89839,90148,39354,983
Cost of revenue29,98130,71535,34942,64948,497
Gross profit3,6153,1834,5525,7446,486
SG&A2,3392,2482,9934,0524,698
Operating income1,2769351,5591,6921,788
Pretax income1,4761,3141,6631,9022,025
Income tax607540581754710
Net income attributable to owners8527601,0401,1331,275
Operating margin3.8%2.8%3.9%3.5%3.3%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 15%
Property, plant and equipment 29%
5%
Investment securities 9%
Other assets 42%

Funding

Interest-bearing debt 21%
Other liabilities 35%
Equity 44%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Feb 2022FY ending Feb 2023FY ending Feb 2024FY ending Feb 2025FY ending Feb 2026
Cash and equivalents¥7.79B¥6.25B¥7.59B¥6.64B¥5.75B
Total assets¥29.1B¥27.5B¥31.7B¥34.2B¥37.6B
Net assets¥11.9B¥12.6B¥13.8B¥14.7B¥16.3B
Share capital¥917M¥917M¥917M¥917M¥917M
Property, plant and equipment¥9.86B¥9.59B¥9.12B¥10B¥10.9B
Intangible assets excluding goodwill¥1.71B¥1.48B¥860.3M¥989.6M¥937.3M
Goodwill¥1.54B¥1.3B¥692.8M¥816.4M¥774.7M
Investment securities¥1.1B¥1.32B¥2.1B¥2.41B¥3.4B
Current assets¥14.6B¥13.2B¥16.7B¥18B¥19.1B
Current liabilities¥8.42B¥7.45B¥10.4B¥11.7B¥11.6B
Short-term borrowings¥170M¥170M¥1.34B¥1.18B¥530M
Long-term borrowings¥7.37B¥6.06B¥5.72B¥6.05B¥7.25B
Bonds————¥150M
Interest-bearing debt————¥7.93Bderived
Total liabilities¥17.2B¥14.9B¥17.8B¥19.5B¥21.2B
Non-controlling interests¥544.8M¥558.5M¥600.3M¥614.3M¥653.7M
Equity attributable to owners of parent¥11.4B¥12B¥12.9B¥13.9B¥14.8B
Retained earnings¥9.95B¥10.6B¥11.4B¥12.4B¥12.8B
Treasury stock-¥541.6M-¥539.8M-¥537.9M-¥531.7M-¥7.1M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第41期(2025/03/01-2026/02/28)

    ID S100Y4Y92026-05-19Open
  • EDINET (FSA Japan)

    有価証券報告書-第40期(2024/03/01-2025/02/28)

    ID S100VT822025-05-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第39期(2023/03/01-2024/02/29)

    ID S100THFR2024-05-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第38期(2022/03/01-2023/02/28)

    ID S100QTLN2023-05-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第37期(令和3年3月1日-令和4年2月28日)

    ID S100O4HK2022-05-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第36期(令和2年3月1日-令和3年2月28日)

    ID S100LEQA2021-05-27Open

Extracted from XBRL: 53 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.